# A Real-world Study Observing Treatment Patterns and Clinical Results for Patients in China With Hormone Receptor-positive, HER2-negative Metastatic Breast Cancer.

> **NCT07743944** · — · RECRUITING · sponsor: **AstraZeneca** · enrollment: 2000 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07743944
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-05
- **Primary completion:** 2031-08-04
- **Final completion:** 2031-08-04
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2026-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07743944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07743944, "A Real-world Study Observing Treatment Patterns and Clinical Results for Patients in China With Hormone Receptor-positive, HER2-negative Metastatic Breast Cancer.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07743944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*